Mirexus Biotechnologies Inc. raises $12 million to finance factory, fund business development, and deepen R&D
Guelph, ON – June 29, 2017 – Mirexus Biotechnologies Inc. (Mirexus) announced that it has closed an investment round of $12 million. Mirexus is a safe and natural nanomaterials company based in Guelph, Ontario. The company has commercialized a product called PhytoSpherix™, a novel technology based on polysaccharide nanoparticles that can be used in a wide variety of markets ranging from cosmetics to nutraceuticals to applications in human health. The funds will be used to finance a factory to produce PhytoSpherix™ and to fund at least three years of operations as the company grows.
Adventus conducted a market research study for Mirexus in 2008 to identify and profile potential markets for a new technology.
Read the full story including comments from Mirexus President and CEO, Dr. Phil Whiting.